34 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.

Amgen
TRPA1 channels as targets for resveratrol and related stilbenoids.

Sapienza University of Rome
Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.

University of Eastern Piedmont
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.

University of Siena
Effect of acyclic monoterpene alcohols and their derivatives on TRP channels.

Sapienza University of Rome
Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.

Raqualia Pharma
Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.

Genomics Institute of The Novartis Research Foundation
Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonists.

Astrazeneca
3-Ylidenephthalides as a new class of transient receptor potential channel TRPA1 and TRPM8 modulators.

Sapienza University of Rome
Biaryl tetrazolyl ureas as inhibitors of endocannabinoid metabolism: modulation at the N-portion and distal phenyl ring.

Sapienza University of Rome
Tetrahydro-ß-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.

Sapienza University of Rome
Modulation of thermo-transient receptor potential (thermo-TRP) channels by thymol-based compounds.

Sapienza University of Rome
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.

Ferrara University
New tetrazole-based selective anandamide uptake inhibitors.

Sapienza University of Rome
Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.

Sapienza University of Rome
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.

University of Ferrara
Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.

Janssen Pharmaceutica
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).

Universita` Del Piemonte Orientale
Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.

Pfizer
(-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels.

Sapienza University of Rome
Taste-guided identification of high potency TRPA1 agonists from Perilla frutescens.

Università
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.

Florence University
A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 Antagonists.

Genentech
Structural and in Vitro Functional Characterization of a Menthyl TRPM8 Antagonist Indicates Species-Dependent Regulation.

Marshall University
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity.

University of Siena
Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.

National Research Council
Iodine-mediated cyclization of cannabigerol (CBG) expands the cannabinoid biological and chemical space.

University of Naples Federico II
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.

University of Eastern Piedmont
Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.

Pharmaron-Beijing